Carbidopa, Levodopa and Entacapone 37.5 mg Tablet, film coated

Carbidopa, Levodopa and Entacapone 37.5 mg/1 tablets are a combination medication used to manage symptoms of Parkinson's disease. This formulation helps improve motor function and reduce tremors.

Carbidopa, Levodopa and Entacapone 37.5 mg/1 tablets are primarily used to treat Parkinson's disease. The combination of these active ingredients works to increase dopamine levels in the brain, which helps alleviate symptoms such as stiffness, tremors, and poor muscle control. This medication is often prescribed when other treatments are not effective or when a more comprehensive approach is needed.

Common effects of Carbidopa, Levodopa and Entacapone 37.5 mg/1 tablets may include nausea, dizziness, and headache. Some users might experience involuntary movements or changes in mood. These effects can vary and may improve over time as the body adjusts to the medication.

Carbidopa, Levodopa and Entacapone 37.5 mg/1 tablets should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients with certain medical conditions, such as liver or kidney disease, should discuss their health status with a doctor before starting this medication.

Carbidopa, Levodopa and Entacapone 37.5 mg/1 tablets may interact with other medications, including antidepressants, antipsychotics, and blood pressure drugs. Alcohol and certain dietary supplements can also affect how this medication works. Always inform your healthcare provider about all the medications and supplements you are taking.